Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1982;274(3-4):229-47.
doi: 10.1007/BF00403726.

Xeroderma pigmentosum patients from Germany: clinical symptoms and DNA repair characteristics

Xeroderma pigmentosum patients from Germany: clinical symptoms and DNA repair characteristics

E Fischer et al. Arch Dermatol Res. 1982.

Abstract

Dermatologic, ophthalmologic, and neurologic examinations were carried out on 33 patients with clinical symptoms of xeroderma pigmentosum (XP). Complementation groups were determined for 23 patients. Types of tumors and complementation group were found to be related in the following way: In the XP variant groups basaliomas were the most frequently occurring malignant tumors, whereas in the D group pigmentary tumors, such as melanotic precanceroses and melanomas prevailed; in the A and the C group, spinaliomas seem to be the most frequent malignomas. The DNA repair activity was measured using colony-forming ability and unscheduled DNA synthesis. Colony-forming ability was quantitated as a function of 12 different UV doses and expressed in terms of D0. Unscheduled DNA synthesis was determined autoradiographically by establishing dose-response curves, which were analyzed by the characteristic value of linear regression. G0, defined as the linear increase in the mean number of silver grains per nucleus when the UV dose is multiplied by the factor of e (i.e., 2.72), was derived from the slopes of the regression lines. The repair capability of XP fibroblast lines was classified on the basis of D0 and G0.

PubMed Disclaimer

References

    1. Proc Natl Acad Sci U S A. 1975 Jan;72(1):219-23 - PubMed
    1. Arch Toxicol. 1980 Mar;44(1-3):197-207 - PubMed
    1. Mutat Res. 1980 May;70(3):373-81 - PubMed
    1. Br J Dermatol. 1981 Jul;105(1):1-12 - PubMed
    1. Carcinogenesis. 1980 Aug;1(8):647-55 - PubMed

Publication types

MeSH terms